Autologous Conditioned Serum: Functional and Clinical Results

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 6, 2017

Primary Completion Date

September 28, 2018

Study Completion Date

September 28, 2018

Conditions
Knee OsteoarthritisOsteoarthritis, KneeCartilage Degeneration
Interventions
DRUG

Autologous Conditioned Serum

"Fifteen patients with clinical and radiological signs of OA of the knee were recruited for this study. 50mL of whole blood were taken using a special syringe containing CrSO4-coated grade glass beads in order to promote IL-1ra synthesis and aggregation.The incubation period lasted 7 hours after which, the blood-filled syringes were centrifuged and the serum supernatant was filtered and aliquoted into four 3mL portions. The aliquots were stored at -20oC until their use was necessary.~Patients received 1 intra-articular injection for 4 consecutive weeks at the site of OA."

Trial Locations (1)

20132

Ospedale San Raffaele, Milan

All Listed Sponsors
lead

Ospedale San Raffaele

OTHER

NCT03850080 - Autologous Conditioned Serum: Functional and Clinical Results | Biotech Hunter | Biotech Hunter